Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury

NCT04710550 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04710550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04710550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Utility of [18F]3F4AP for Demyelination Imaging in Controls, Neurodegeneration and Traumatic Brian Injury
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
January 25, 2021
Completion date
December 1, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, brain injuries, traumatic, demyelinating disorder